SCHEMBL11499202

SCHEMBL11499202

O=C(Nc1nc(-c2ccc(Cl)cc2)cs1)c1cccnc1

nearest known ligand 0.80

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 5/20 0.80
▸ ALDH1A1 P00352 4/20 0.79
▸ MAPK1 P28482 1/20 0.79
▸ ABL1 P00519 2/20 0.78
▸ SMN1; SMN2 Q16637 4/20 0.74
▸ KMT2A Q03164 3/20 0.70
▸ MAPT P10636 2/20 0.64
▸ MEN1 O00255 2/20 0.64
▸ CYP1A2 P05177 1/20 0.64
▸ CYP2C19 P33261 1/20 0.64
▸ PKM P14618 1/20 0.61
▸ NPC1 O15118 1/20 0.61
▸ ADORA3 P0DMS8 1/20 0.61
▸ MPL P40238 1/20 0.61
▸ KDM4E B2RXH2 1/20 0.59
▸ TDP1 Q9NUW8 1/20 0.59
▸ PARP1 P09874 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12249057 0.89 LMNA (0.82) LMNAALDH1A1MAPK1ABL1SMN1; SMN2
SCHEMBL11469127 0.89 LMNA (1.00) LMNAALDH1A1MAPK1ABL1SMN1; SMN2
SCHEMBL25287793 0.89 LMNA (0.90) LMNAALDH1A1MAPK1ABL1SMN1; SMN2
SCHEMBL5698578 0.88 LMNA (1.00) LMNAALDH1A1MAPK1ABL1SMN1; SMN2
SCHEMBL12248945 0.88 LMNA (0.80) LMNAALDH1A1MAPK1ABL1SMN1; SMN2
SCHEMBL6154942 0.87 ABL1 (1.00) LMNAALDH1A1MAPK1ABL1SMN1; SMN2
SCHEMBL30263326 0.85 LMNA (0.80) LMNAALDH1A1MAPK1ABL1SMN1; SMN2
SCHEMBL12301022 0.85 LMNA (0.75) LMNAALDH1A1MAPK1ABL1SMN1; SMN2
SCHEMBL2304197 0.82 NPC1 (0.66) LMNAALDH1A1MAPK1ABL1KMT2A
SCHEMBL6249035 0.81 SCD (0.74) LMNAALDH1A1KMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4225610-A TREATMENT OF RHEUMATOID ARTHRITIS PIERRE FABRE, S.A. (FR) 1980-09-30 — — US disclosed
Send feedback